Quick Facts
FONT-SIZE Plus   Neg
Share SHARE

Dr. Reddy's Launches Zenatane In US Market - Quick Facts

Dr. Reddy's Laboratories (RDY: Quote) announced it has launched Zenatane in 20 mg and 40 mg, a therapeutically equivalent generic version of Accutane, in the US market on March 28, 2013 following the approval by the FDA of ANDA for Zenatane 10 mg, 20 mg and 40 mg.

The company noted that total market had U.S. sales of approximately $309 million for the most recent twelve months ending January 2013 according to IMS Health.

Click here to receive FREE breaking news email alerts for and others in your portfolio

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Editors Pick
Economic confidence in the eurozone picked up in October from a 10-month low, with broad based improvement across sectors, the results of a survey by the European Commission showed Thursday. The economic confidence index rose unexpectedly to 100.7 in October from 99.9 in the prior month. The score was expected to fall to 99.7. Visa Inc., the world's largest payment card processor, said Wednesday that its fourth quarter profit fell 10% from last year, hurt mainly by a hefty litigation provision even as revenue increased 9%. However, the company's quarterly earnings per share, excluding items, came in above analysts' expectations as did its quarterly revenue. Stocks saw considerable volatility following the Federal Reserve's monetary policy meeting on Wednesday but maintained a negative bias before closing modestly lower. The losses on the day partly offset the rally seen in the previous session.
comments powered by Disqus
FREE Newsletters, Analysis & Alerts

 

Stay informed with our FREE daily Newsletters and real-time breaking News Alerts. Sign up to receive the latest information on business news, health, technology, biotech, market analysis, currency trading and more.